• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球结核病负担和流行病学。

Global burden and epidemiology of tuberculosis.

机构信息

Stop TB Department, World Health Organization, 1211 Geneva 27, Switzerland.

出版信息

Clin Chest Med. 2009 Dec;30(4):621-36, vii. doi: 10.1016/j.ccm.2009.08.017.

DOI:10.1016/j.ccm.2009.08.017
PMID:19925958
Abstract

Tuberculosis (TB) ranks second only to human immunodeficiency virus as a cause of death from an infectious agent (1.77 million deaths from TB in 2007). Global targets for reductions in the epidemiologic burden of TB have been set for 2015 and 2050 within the context of the Millennium Development Goals and the Stop TB Partnership. Achieving these targets is the focus of national and international efforts in TB control, and demonstrating whether or not they are achieved is of major importance. This article discusses: the methods used by the World Health Organization to estimate the global burden of TB; estimates of incidence, prevalence, and mortality for 2007, combined with assessment of progress toward the 2015 targets for reductions in these indicators based on trends since 1990 and projections up to 2015; trends in TB notifications and case detection rates; and prospects for elimination of TB by 2050.

摘要

结核病(TB)是仅次于人类免疫缺陷病毒(HIV)的传染病死因(2007 年有 177 万人死于结核病)。全球范围内设定了在千年发展目标和遏制结核病伙伴关系框架下,到 2015 年和 2050 年降低结核病流行负担的目标。实现这些目标是国家和国际结核病控制工作的重点,展示这些目标是否已经实现非常重要。本文讨论了:世界卫生组织用于估计全球结核病负担的方法;2007 年发病率、患病率和死亡率的估计数,以及根据 1990 年以来的趋势和到 2015 年的预测,对减少这些指标的 2015 年目标进展情况的评估;结核病报告和病例检出率的趋势;以及到 2050 年消除结核病的前景。

相似文献

1
Global burden and epidemiology of tuberculosis.全球结核病负担和流行病学。
Clin Chest Med. 2009 Dec;30(4):621-36, vii. doi: 10.1016/j.ccm.2009.08.017.
2
Global epidemiology of tuberculosis.全球结核病流行病学。
Semin Respir Crit Care Med. 2013 Feb;34(1):3-16. doi: 10.1055/s-0032-1333467. Epub 2013 Mar 4.
3
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
4
Stopping tuberculosis in the 21st century: goals and strategies.在 21 世纪终止结核病:目标与策略。
Respirology. 2010 Jan;15(1):32-43. doi: 10.1111/j.1440-1843.2009.01673.x.
5
[How to cope with the global tuberculosis burden--experiences and perspectives for Japan's international cooperation].[如何应对全球结核病负担——日本国际合作的经验与展望]
Kekkaku. 2005 Feb;80(2):89-94.
6
Global epidemiology of tuberculosis.全球结核病流行病学
Cold Spring Harb Perspect Med. 2014 Oct 30;5(2):a017798. doi: 10.1101/cshperspect.a017798.
7
Epidemiology of tuberculosis in the Americas: the Stop TB strategy and the millennium development goals.美洲地区的结核病流行病学:终止结核病战略与千年发展目标
Int J Tuberc Lung Dis. 2009 Aug;13(8):969-75.
8
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.结核病负担日益加重:全球趋势及与艾滋病流行的相互影响
Arch Intern Med. 2003 May 12;163(9):1009-21. doi: 10.1001/archinte.163.9.1009.
9
Clinical tuberculosis and treatment outcomes.临床结核病与治疗结果。
Int J Tuberc Lung Dis. 2010 Jun;14(6):683-8.
10
Global epidemiology of tuberculosis: prospects for control.全球结核病流行病学:控制前景
Semin Respir Crit Care Med. 2008 Oct;29(5):481-91. doi: 10.1055/s-0028-1085700. Epub 2008 Sep 22.

引用本文的文献

1
Microbiota of Saliva: A Non-invasive Diagnostic Tool.唾液微生物群:一种非侵入性诊断工具。
Indian J Microbiol. 2024 Jun;64(2):328-342. doi: 10.1007/s12088-024-01219-4. Epub 2024 Mar 4.
2
Trends in the prevalence and economic burden of hypertension and its socioeconomic disparities in rural southwestern China: two repeated cross-sectional studies.中国西南农村高血压患病率及经济负担的变化趋势及其社会经济差异:两项重复横断面研究。
BMJ Open. 2023 Nov 17;13(11):e076694. doi: 10.1136/bmjopen-2023-076694.
3
Design, Synthesis, and Biological Evaluation of Novel Thiazolidinone-Containing Quinoxaline-1,4-di--oxides as Antimycobacterial and Antifungal Agents.
新型含噻唑烷酮的喹喔啉-1,4-二氧化物作为抗分枝杆菌和抗真菌剂的设计、合成及生物学评价
Front Chem. 2020 Aug 6;8:598. doi: 10.3389/fchem.2020.00598. eCollection 2020.
4
Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.触珠蛋白和可溶性CD163检测在结核性与恶性胸腔积液鉴别诊断中的临床价值
Medicine (Baltimore). 2019 Oct;98(42):e17416. doi: 10.1097/MD.0000000000017416.
5
A new mathematical model to identify contacts with recent and remote latent tuberculosis.一种用于识别近期和远期潜伏性肺结核接触者的新数学模型。
ERJ Open Res. 2019 Jun 10;5(2). doi: 10.1183/23120541.00078-2019. eCollection 2019 Apr.
6
Identification of HLA-DQA1 as a Susceptibility Gene for Spinal Tuberculosis by Exome Sequencing.外显子组测序鉴定 HLA-DQA1 为脊柱结核易患基因。
Med Sci Monit. 2018 May 24;24:3442-3449. doi: 10.12659/MSM.907864.
7
Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.通过蛋白质组学方法鉴定区分结核性和恶性胸腔积液的10种候选生物标志物
Yonsei Med J. 2017 Nov;58(6):1144-1151. doi: 10.3349/ymj.2017.58.6.1144.
8
Seasonality and trend analysis of tuberculosis in Lahore, Pakistan from 2006 to 2013.2006年至2013年巴基斯坦拉合尔结核病的季节性和趋势分析。
J Epidemiol Glob Health. 2015 Dec;5(4):397-403. doi: 10.1016/j.jegh.2015.07.007. Epub 2015 Aug 28.
9
The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis.抗逆转录病毒疗法对HIV阳性患者结核病治疗期间死亡率的影响:一项系统评价和荟萃分析。
PLoS One. 2014 Nov 12;9(11):e112017. doi: 10.1371/journal.pone.0112017. eCollection 2014.
10
Synthesis and antimycobacterial activity of 2,1'-dihydropyridomycins.2,1'-二氢吡啶霉素的合成及其抗分枝杆菌活性
ACS Med Chem Lett. 2012 Dec 18;4(2):264-8. doi: 10.1021/ml300385q. eCollection 2013 Feb 14.